TheraVet Balance Sheet Health
Financial Health criteria checks 3/6
TheraVet has a total shareholder equity of €5.3M and total debt of €1.5M, which brings its debt-to-equity ratio to 27.5%. Its total assets and total liabilities are €7.1M and €1.9M respectively.
Key information
27.5%
Debt to equity ratio
€1.45m
Debt
| Interest coverage ratio | n/a |
| Cash | €713.56k |
| Equity | €5.28m |
| Total liabilities | €1.87m |
| Total assets | €7.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ALVET's short term assets (€1.2M) exceed its short term liabilities (€874.4K).
Long Term Liabilities: ALVET's short term assets (€1.2M) exceed its long term liabilities (€994.7K).
Debt to Equity History and Analysis
Debt Level: ALVET's net debt to equity ratio (14%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if ALVET's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALVET has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ALVET has less than a year of cash runway if free cash flow continues to grow at historical rates of 1.2% each year.